Startseite Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer
Artikel Open Access

Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer

  • Yong Gao , Xuerong Zeng und Xinhong Liao EMAIL logo
Veröffentlicht/Copyright: 9. August 2023

Abstract

This study aimed to assess the correlation among the peak intensity (PI) values of quantitative parameters, microvessel density (MVD), microvessel maturity, and International Society of Urological Pathology (ISUP) grades in biopsy specimens from prostate cancer (PCa) patients. The study population included PCa patients who underwent targeted and systematic biopsy, without radiation or chemohormonal therapy before biopsy. Contrast-enhanced transrectal ultrasonography (CE-TRUS) was performed in all patients before biopsy. Contrast-enhancement patterns and PI values of quantitative parameters were observed. Tumor tissue samples were immunostained for CD31 expression. MVD, microvessel maturity, and ISUP grades were determined in prostate biopsy specimens. Based on the contrast enhancement patterns of prostate lesions, 16 patients were assigned to a low-enhancement group and 45 to a high-enhancement group. The number of mature vessels, MVD, mature vessel index, and ISUP grades were all higher in the high-enhancement group than in the low-enhancement group (all P < 0.05). The immature vessel index was lower in the high-enhancement group than in the low-enhancement group (P < 0.05). The PI value was positively correlated with the number of mature vessels (r = 0.372). In conclusion, enhancement patterns on CE-TRUS can reflect microvessel maturity in PCa. The PI value was positively correlated with the number of mature vessels.

1 Introduction

The incidence of prostate cancer (PCa) has increased rapidly in recent years around the globe [1]. PCa is a biologically heterogeneous disease. With a timely diagnosis of PCa (recurrent or primary), curative treatment can be provided to patients. Moreover, systemic treatment for localized advanced PCa can offer promising results in terms of disease control and improvement in quality of life [2]. However, some patients with organ-confined PCa eventually develop metastases [3]. In 2014, the International Society of Urological Pathology (ISUP) held a consensus conference that proposed the replacement of Gleason scores with five grades of PCa [4]. ISUP grade is more accurate in predicting disease progression. Grade 1 is the lowest ISUP grade, in which the survival rate without biochemical recurrence is 94.6% [5]. However, Grade 5 is the highest ISUP grade, in which the survival rate without biochemical recurrence is 34.5%. A higher ISUP grade may indicate more aggressive PCa with the worst prognosis [6].

Angiogenesis in PCa is one of the potential pathways promoting the heterogeneity of the disease. Studies have shown that microvessel density (MVD) is closely related to the progression and metastasis of PCa [7]. In previous studies, researchers have used different imaging techniques, such as ultrasonography, positron emission tomography, magnetic resonance imaging, and computed tomography, to evaluate MVD by direct measurement of single or combined parameters [8,9]. Currently, contrast-enhanced transrectal ultrasonography (CE-TRUS) is being used for this purpose. Lee et al. established that the correlation between the maximum intensity of contrast-enhanced ultrasound (CEUS) and the count of CD31-positive microvessels is statistically significant [10]. Jiang et al. suggested a statistically significant increase in the peak intensity (PI) value of PCa (assessed using CEUS) with higher Gleason scores and MVD [11].

However, the prognostic value of MVD in PCa is contradictory. Its prognostic significance is still unclear. Some studies have found that MVD does not match the changes in tumor blood vessels after anti-angiogenic therapy for PCa because tumor angiogenesis is a complex process [12]. Tumor blood vessels require not only quantitative evaluation but also analysis of the morphology, structure, and function. Most of the new blood vessels in invasive PCa may be immature in morphology and function, lacking complete membrane and pericyte. The connections between endothelial cells may be loose. Tumor cells may be easier to penetrate, leak, and transfer because of the reduced structural barriers [13]. Therefore, MVD is not considered a useful parameter in the prediction of PCa prognosis [14]. Tumor microvessel maturity, which is defined by immature blood vessels, plays a critical role in the development of PCa [15]. Researchers observed a strong association between the size and shape of the microvessels and the incidence of bone metastases or cancer death in several years following diagnosis [16]. In some studies of anti-angiogenic therapy for PCa, especially castration-resistant PCa, efficacy was not significant. One of the reasons may be related to the complex angiogenesis mode and microvascular maturity of the tumor [17]. However, there is no definitive method for the measurement of the degree of microvessel maturity. Information about the relationships among contrast enhancement patterns, the PI values of quantitative parameters, microvessel maturity, and ISUP grades are limited. Therefore, the discovery of a suitable non-invasive imaging method, which can be used to assess both microvessel maturity and the ISUP grade, could be valuable in selecting targets for prostate biopsies. This knowledge could change biopsy strategies, leading to a more appropriate therapeutic strategy. Therefore, in the present study, we aimed to identify whether the contrast enhancement patterns and PI values of quantitative parameters can be used to non-invasively evaluate the microvessel maturity and the ISUP grade of PCa.

2 Materials and methods

2.1 Patients

In this retrospective study, we included 61 patients with prostatic adenocarcinoma, who did not undergo treatment previously. These patients were admitted to the Clinic of Urology from January 2019 to June 2020 with increased prostate-specific antigen (PSA) levels in serum. All tumors were diagnosed to be primary, without previous therapy. In this study, we excluded patients who underwent PCa-related therapies, including radiation therapy, chemotherapy, and androgen deprivation therapy. The local Ethics Committee approved this study (Protocol number: 2021KY-E-238), and all patients gave written informed consent before their enrollment in the study.

2.2 CE-TRUS imaging

All patients included in this study underwent CE-TRUS before prostate biopsy. The ultrasound equipment used was the LOGIQ E9 system (GE Healthcare, Milwaukee, WI, USA) with a transrectal probe operating at a frequency of 3–9 MHz. During CE-TRUS, 2.4 mL of SonoVue (Bracco, Milan, Italy) was administered intravenously as a rapid bolus injection, followed by a 5 mL saline flush. The acoustic power of the equipment was set at a mechanical index of 0.10. The contrast imaging plane was considered the transverse plane of the CE-TRUS abnormality. The results of the imaging examinations were saved in a DICOM format.

2.3 Image and data analyses

Prominent differences exist in the contrast enhancement of peripheral zone (PZ) lesions and that of transition zone lesions. The normal inner gland and coexisting benign prostate hyperplasia often appear to be hypervascular; therefore, regions of interest (ROIs) were drawn only on the PZ biopsy sites on CE-TRUS images. However, in the case of systematic biopsies, ROIs with diameters of approximately 5 mm were traced around the biopsy sites. Furthermore, ROIs were drawn as closely as possible to encompass the CE-TRUS abnormalities in the case of targeted biopsies. The CE-TRUS image analysis was performed individually by two sonographers with more than 10 years of work experience, who were blinded to all clinical and pathological information. If the conclusions obtained by these sonographers were inconsistent, a consistent conclusion would be reached after discussion. According to the enhancement patterns of prostate lesions, the patients in this study were divided into low- and high-enhancement groups. An abnormal imaging lesion was defined with reference to the surrounding normal prostate tissue or compared to the other side, with asymmetric or asynchronous enhancement areas. Based on the normal internal gland, if the enhancement level was similar to or higher than that of the internal gland, high enhancement was defined. However, an enhancement level lower than that of the internal gland was defined as low enhancement. In the case of uneven enhancement, the enhancement level was based on the enhancement in more than 50% of the lesion area. Time-intensity curve (TIC) analysis for each ROI was performed using the TIC analysis software of LOGIQ E9.

2.4 Prostate biopsy

Within 1 week after CE-TRUS, 2–3 targeted biopsy cores were taken from areas of abnormal CE-TRUS findings, and a systematic 12-core transrectal ultrasound-guided prostate biopsy was performed by a sonographer with more than 10 years of experience in the field. Core samples were extracted using an automatic biopsy gun (C. R. Bard, Covington, GA, USA) that triggers an 18 G needle with a core length of 25 cm. Specimens were marked based on the site of the biopsy.

2.5 Pathological analysis and immunostaining

Tissue samples from PCa patients were extracted using ultrasound-guided targeted or systematic biopsy. The grading of tumors on needle biopsy samples was undertaken in accordance with the ISUP grades. Each sample was assigned to one of the following ISUP grades: grade 1 (GS ≤ 3 + 3), grade 2 (GS 3 + 4), grade 3 (GS 4 + 3), grade 4 (GS 4 + 4, 3 + 5, and 5 + 3), and grade 5 (GS 9–10).

The biopsy specimens of prostate tissues were immersed in formalin for 5–6 h in preparation for optimal immunostaining and then these sample tissues were embedded in paraffin. A pathologist, with more than 10 years of experience in this field, reviewed all the histological slides from ultrasound-guided targeted or systematic biopsies and selected a few slides for quantitative evaluation. The selected samples were stained for CD31 using the “hot spot” method introduced by Weidner et al. [18] for the assessment of the MVD. After staining, the most vascularized areas were identified using a fluorescence microscope with a 10× objective, and three fields were selected for counting the vessels at 20× magnification. The average count was designated as the MVD. Without a vascular luminal structure, single vascular endothelial cell buds, strand-shaped endothelial cells, or clustered endothelial cells were considered as immature vessel. The vessels that showed an obvious luminal structure were considered relatively mature vessels. The calculations used for mature and immature vessel indices are as follows:

Mature vessel index = Number of relatively mature vessels / MVD

and

Immature vessel index = Number of immature vessels / MVD .

Paraffin-embedded PCa tissue sections with a thickness of 4 μm were obtained. The sections were mounted on glass slides coated with silane. These sections then underwent deparaffinization using xylene and rehydration with graded alcohol solutions. The treated sections were pressed with citric acid. Next, they were rinsed with phosphate-buffered saline (PBS) and treated with 50 μL of 3% H2O2 solution for 10 min at room temperature for inactivation of endogenous peroxidase. Non-immune goat serum (50 μL) was added to each section for incubation at room temperature for 10 min. The sections were further incubated with CD31 antibody (MAB-0720) at room temperature for 60 min. After incubation with the primary antibody, the sections were washed with PBS three times. Then, the sections were again incubated with 50 μL of the immunochromogenic reagent D-3004-15 (secondary antibody, horseradish peroxidase [HRP] labeled) at room temperature for 30 min. After adding 100 μL of freshly prepared DAB chromogenic solution to the sections and washing them thrice, the sections were stained with DAB chromogenic solution (100 μL), incubated for 3–5 min, and photographed using an optical microscope (Olympus Corporation, Tokyo, Japan). The sections were rinsed with tap water, counterstained with hematoxylin, rinsed with PBS to return to blue, dehydrated with gradient alcohol, rendered transparent with xylene, and finally sealed with neutral gum. The cytoplasm of vascular endothelial cells of all study sections showed a strong positive reaction.

2.6 Statistical analysis

All analyses were conducted using SPSS 25.0 (SPSS Inc., Chicago, IL, USA). The comparisons between sample means of the two groups were performed using an independent sample t-test or non-parametric Mann–Whitney test. Correlations were analyzed using Pearson or Spearman correlation analysis. A statistically significant difference was indicated by P < 0.05.

3 Results

3.1 Patient characteristics

The mean age of the patients included in this study was 68.2 ± 9.5 years (range, 50–90 years). The median value of the pretreatment serum PSA was 74.45 (range, 5.12–1000.00 ng/mL). The final pathological staging for the 61 patients with PCa was recorded as 7, 6, 16, 13, and 19 cases with ISUP grades 1–5, respectively.

3.2 Differences in PI, MVD, microvessel maturity, and ISUP grades between PCa cases with different contrast enhancement levels on CE-TRUS

The number of mature vessels, MVD, mature vessel index, and ISUP grade were all higher in the high-enhancement group than in the low-enhancement group; however, the immature vessel index was lower in the high-enhancement group than in the low-enhancement group (Table 1).

Table 1

Comparison of PI, MVD, microvessel maturity, and ISUP grades between PCa cases with different contrast enhancement levels on CE-TRUS

n Mature vessels Immature vessels MVD Mature vessel index Immature vessel index ISUP grade
Low enhancement 16 3.35 ± 1.91 15.08 ± 6.30 18.43 ± 6.46 0.19 ± 0.12 0.81 ± 0.12 3
High enhancement 45 6.18 ± 3.44 17.19 ± 6.26 23.37 ± 6.45 0.27 ± 0.14 0.73 ± 0.14 4
t/z −3.118 −1.158 −2.631 −2.017 −2.017 −2.224
P 0.003 0.252 0.011 0.048 0.048 0.026

3.3 Correlations among PI, MVD, microvessel maturity, and ISUP grade in PCa

The PI value was positively correlated with the number of mature vessels (Table 2, Figures 1 and 2). However, no correlations were observed among PI, MVD, number of immature vessels, mature vessel index, immature vessel index, and ISUP grades.

Table 2

Correlations among PI, MVD, microvessel maturity, and ISUP grades in PCa

PI
R P
Mature vessels 0.340 0.007
Immature vessels 0.081 0.536
MVD 0.220 0.089
Mature vessel index 0.170 0.189
Immature vessel index −0.170 0.189
ISUP grade 0.234 0.069
Figure 1 
                  Representative images of CE-TRUS showing high enhancement levels and immunohistochemical staining. (a) The lesion in the left PZ of the prostate is shown with a high enhancement level on CE-TRUS (red arrow) with an ISUP grade of 5. (b) Targeted biopsy tissue stained for CD31 expression. Tumor cell nuclei (blue) are distributed in nests. Most dense groups of microvessels contain relatively mature vessels (red arrow), and the yellow arrow indicates an immature vessel.
Figure 1

Representative images of CE-TRUS showing high enhancement levels and immunohistochemical staining. (a) The lesion in the left PZ of the prostate is shown with a high enhancement level on CE-TRUS (red arrow) with an ISUP grade of 5. (b) Targeted biopsy tissue stained for CD31 expression. Tumor cell nuclei (blue) are distributed in nests. Most dense groups of microvessels contain relatively mature vessels (red arrow), and the yellow arrow indicates an immature vessel.

Figure 2 
                  Representative images of CE-TRUS showing low enhancement levels and immunohistochemical staining. (a) The lesion in the left PZ of the prostate is shown with a low enhancement level on CE-TRUS (red arrow) with an ISUP grade of 4. (b) Targeted biopsy tissue stained for CD31 expression. Tumor cell nuclei (blue) are distributed individually throughout the tissue. Most dense areas of microvessels (brown–yellow) contain relatively immature vessels (red arrow).
Figure 2

Representative images of CE-TRUS showing low enhancement levels and immunohistochemical staining. (a) The lesion in the left PZ of the prostate is shown with a low enhancement level on CE-TRUS (red arrow) with an ISUP grade of 4. (b) Targeted biopsy tissue stained for CD31 expression. Tumor cell nuclei (blue) are distributed individually throughout the tissue. Most dense areas of microvessels (brown–yellow) contain relatively immature vessels (red arrow).

3.4 Correlations among ISUP grades, microvessel maturity, and MVD in PCa

The ISUP grade of PCa specimens was positively correlated with the number of immature vessels and MVD (Table 3, Figures 3 and 4). However, no correlations were found among ISUP grade, number of mature vessels, mature vessel index, and immature vessel index.

Table 3

Correlations among ISUP grade, microvessel maturity, and MVD in PCa

ISUP grade
R P
Mature vessels −0.005 0.967
Immature vessels 0.465 0.000
MVD 0.417 0.001
Mature vessel index −0.233 0.071
Immature vessel index 0.223 0.071
Figure 3 
                  Targeted biopsy tissues from the PCa case with ISUP grade of 2, stained for CD31. (a) Abundant microvessels in tumor tissues (red box). (b) Tumor cell nuclei (blue) were small and poorly differentiated. The numbers of mature vessels (red arrow) and immature vessels (yellow arrow) were almost equal.
Figure 3

Targeted biopsy tissues from the PCa case with ISUP grade of 2, stained for CD31. (a) Abundant microvessels in tumor tissues (red box). (b) Tumor cell nuclei (blue) were small and poorly differentiated. The numbers of mature vessels (red arrow) and immature vessels (yellow arrow) were almost equal.

Figure 4 
                  Targeted biopsy tissues from the PCa case with ISUP grade of 5, stained for CD31. (a) Abundant microvessels in tumor tissues (red box). (b) Tumor cell nuclei (blue) were densely distributed in flakes. Most were immature vessels (yellow arrow), with only a few mature vessels (red arrow).
Figure 4

Targeted biopsy tissues from the PCa case with ISUP grade of 5, stained for CD31. (a) Abundant microvessels in tumor tissues (red box). (b) Tumor cell nuclei (blue) were densely distributed in flakes. Most were immature vessels (yellow arrow), with only a few mature vessels (red arrow).

4 Discussion

ISUP grades can accurately predict the aggressiveness and prognosis of PCa [19]. Moreover, angiogenesis plays an important role in the development of PCa [20]. The complex angiogenesis mode and microvascular maturity of the tumor play a critical role in the development of PCa [15,17]. Therefore, a non-invasive imaging technique that can assess both microvessel maturity and ISUP grade could support timely diagnosis and determination of PCa characteristics.

Our results showed that MVD values in PCa cases with high enhancement on CE-TRUS were higher than those in PCa cases with low enhancement. The differences in the enhancement patterns on CE-TRUS images in PCa patients may be mainly due to the different proportions of relative mature vessels in these cases. When the mature vessel index is low, the perfusion of the lesion is poor. Although prostate tumors have abundant microvessels, their contrast enhancement may be at a low level due to the low number of functional mature vessels [21]. Therefore, the immature vessel index in the high-enhancement group was lower than that in the low-enhancement group, whereas the mature vessel index in the high-enhancement group was higher than that in the low-enhancement group. These results suggest that the enhancement pattern on CE-TRUS can reflect microvessel maturity in PCa patients.

Our results also showed that ISUP grading was higher in the high-enhancement group than in the low-enhancement group. A higher ISUP grade indicates worse tumor differentiation and a greater number of immature vessels in PCa. Theoretically, MVD should be higher than the number of immature vessels in the high-enhancement group. However, we obtained a conflicting result in this case.

In the present study, we analyzed the correlations among PI, MVD, microvessel maturity, and ISUP grade. A positive correlation was observed between PI and the number of mature vessels but the correlation was weak (r = 0.340). However, no correlations were observed between PI and MVD or ISUP grade. A possible explanation for such a scenario might be that the PI value we calculated was the average of all the pixels of the ROI at the peak time, but the signals induced by immature and mature vessels in the same ROI could affect each other. Therefore, the PI value that we obtained cannot represent the signal induced by individual immature or mature vessels. Second, the hemodynamics of a tumor is affected by cell proliferation, angiogenesis, and vascular maturity [22]. In this study, the vascular factors may be complicated, which could affect the distribution and metabolism of contrast agents, due to the heterogeneity of the structure and function of the tumor vessels [23]. The contrast parameters might change due to the differences in the number, diameter, and atypia index of microvessels at the edge and center of a lesion. In addition, the increase in vascular permeability, blood viscosity, and blood flow resistance within a tumor might also affect the metabolism of contrast agents [23]. Although the blood supply within the tumor is mainly dependent on the function of vessels, it is also affected by complex factors, such as tumor necrosis, hemorrhage, and fibrosis. Studies have shown that inflammation is a cause of PCa, which may play a crucial role in the occurrence and progression of PCa, including initiation, promotion, malignant transformation, invasion, and metastasis [24]. Some pro-inflammatory cytokines, such as IL-17, may affect several landmark functions of PCa occurrence and development, such as inhibition of proliferation, resistance to cell death, activation invasion, and induction of angiogenesis [25]. In the meantime, each Gleason score is the result of the sum of essentially heterogeneous categories (Gleason patterns [GP]), as each pattern contains several tumor forms. Previous research has shown that the patterns of GP5 and tumor necrosis are associated with poor histopathological characteristics and high residual disease rates [26]. Therefore, simply using PI values to assess the function and status of tumor neovascularization is not accurate.

An important limitation of our study was the limited pathological evaluation due to a lack of correlation of results with prostatectomy. Previous studies reported undergrading of prostatectomy Gleason scores in biopsy samples [27]. Second, the maturity of microvessels needs to be evaluated based on certain indicators, such as size and regularity, which could be considered in future studies. Third, this study had a small sample size. Therefore, further studies with large sample sizes could provide more generalizable results.

5 Conclusion

We conclude that the enhancement pattern on CE-TRUS could reflect the microvessel maturity in PCa tumors. The immature vessel index in the high-enhancement group was lower than that in the low-enhancement group, whereas the mature vessel index in the high-enhancement group was higher than that in the low-enhancement group. ISUP grading was higher in the high-enhancement group than in the low-enhancement group. The PI value was positively correlated with the number of mature vessels.


tel: +86 15977486866

  1. Funding information: This research was funded by National Natural Science Foundation of China Youth Science Fund Project (Grant number: 82001827).

  2. Conflict of interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

  3. Data availability statement: All data generated or used during the study are available from the corresponding author by request.

References

[1] Gandaglia G, Leni R, Bray F, Fleshner N, Freedland S, Kibel A, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877–92.10.1016/j.euo.2021.09.006Suche in Google Scholar PubMed

[2] Mayor de Castro J, Caño Velasco J, Aragón Chamizo J, Andrés Boville G, Herranz Amo F, Hernández Fernández C. Locally advanced prostate cancer. Definition, diagnosis and treatment. Archivos Espanoles de Urologia. 2018;71(3):231–8.Suche in Google Scholar

[3] Bernstein AN, Shoag JE, Golan R, Halpern JA, Schaeffer EM, Hsu WC, et al. Contemporary incidence and outcomes of prostate cancer lymph node metastases. J Urol. 2018;199(6):1510–7.10.1016/j.juro.2017.12.048Suche in Google Scholar PubMed PubMed Central

[4] Samaratunga H, Delahunt B, Yaxley J, Srigley JR, Egevad L. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer. Scand J Urol. 2016;50(5):325–9.10.1080/21681805.2016.1201858Suche in Google Scholar PubMed

[5] Pierorazio PM, Walsh PC, Partin AW, Epstein JI. Prognostic Gleason grade grouping: Data based on the modified Gleason scoring system. BJU Int. 2013;111(5):753–60.10.1111/j.1464-410X.2012.11611.xSuche in Google Scholar PubMed PubMed Central

[6] Egevad L, Delahunt B, Srigley JR, Samaratunga H. International Society of Urological Pathology (ISUP) grading of prostate cancer – An ISUP consensus on contemporary grading. APMIS: Acta Pathologica, Microbiologica et Immunologica Scandinavica. 2016;124(6):433–5.10.1111/apm.12533Suche in Google Scholar PubMed

[7] Strohmeyer D, Strauss F, Rössing C, Roberts C, Kaufmann O, Bartsch G, et al. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma. Anticancer Res: Int J Cancer Research Treat. 2004;24(3a):1797–804.Suche in Google Scholar

[8] Rodjan F, Graaf PD, Valk PVD, Moll AC, Kuijer JPA, Knol DL, et al. Retinoblastoma: value of dynamic contrast- enhanced mr imaging and correlation with tumor angiogenesis. AJNR Am J Neuroradiol. 2012;33(11):2129–35.10.3174/ajnr.A3119Suche in Google Scholar PubMed PubMed Central

[9] Li Q, Cui D, Feng Y, He Y, Shi Z, Yang R. Correlation between microvessel density (MVD) and multi-spiral CT (MSCT) perfusion parameters of esophageal cancer lesions and the diagnostic value of combined CtBP2 and P16INK4A. J Gastrointest Oncol. 2021;12(3):981–90.10.21037/jgo-21-247Suche in Google Scholar PubMed PubMed Central

[10] Lee HJ, Hwang SI, Chung JH, Jeon JJ, Choi JH, Jung HS. Evaluation of tumor angiogenesis in a mouse PC-3 prostate cancer model using dynamic contrast-enhanced sonography. J Ultrasound Med. 2012;31(8):1223–31.10.7863/jum.2012.31.8.1223Suche in Google Scholar PubMed

[11] Jiang J, Chen Y, Zhu Y, Yao X, Qi J. Contrast-enhanced ultrasonography for the detection and characterization of prostate cancer: Correlation with microvessel density and Gleason score. Clin Radiol. 2011;66(8):732–7.10.1016/j.crad.2011.02.013Suche in Google Scholar PubMed

[12] Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Natl Cancer Inst. 2002;94(12):883–93.10.1093/jnci/94.12.883Suche in Google Scholar PubMed

[13] Farhad T, Mehdi M, Farshid A, Mazaher H, Mohammadhatef K, Mohammad Y, et al. Prostate cancer: Relationship between vascular diameter, shape and density and Gleason score in needle biopsy specimens. Adv Biomed Res. 2013;2(2):3.10.4103/2277-9175.107963Suche in Google Scholar PubMed PubMed Central

[14] Tretiakova M, Antic T, Binder D, Kocherginsky M, Liao C, Taxy JB, et al. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays. Hum Pathol. 2013;44(4):495–502.10.1016/j.humpath.2012.06.009Suche in Google Scholar PubMed

[15] Mucci LA, Powolny A, Giovannucci E, Liao Z, Kenfield SA, Shen R, et al. Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. J Clin Oncol. 2009;27(33):5627–33.10.1200/JCO.2008.20.8876Suche in Google Scholar PubMed PubMed Central

[16] Huang Y, Goel S, Duda DG, Fukumura D, Jain RK. Vascular normalization as an emerging strategy to enhance cancer immunotherapy. Cancer Res. 2013;73(10):2943–8.10.1158/0008-5472.CAN-12-4354Suche in Google Scholar PubMed PubMed Central

[17] Sarkar C, Goswami S, Basu S, Chakroborty D. Angiogenesis inhibition in prostate cancer: an update. Cancers. 2020;12(9):2382.10.3390/cancers12092382Suche in Google Scholar PubMed PubMed Central

[18] Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast cancer res. 1995;36(2):169–80.10.1007/BF00666038Suche in Google Scholar PubMed

[19] Offermann A, Hupe MC, Sailer V, Merseburger AS, Perner S. The new ISUP 2014/WHO 2016 prostate cancer grade group system: first résumé 5years after introduction and systemic review of the literature. World J Urol. 2020;38(3):657–62.10.1007/s00345-019-02744-4Suche in Google Scholar PubMed

[20] Eisermann K, Fraizer G. The androgen receptor and VEGF: mechanisms of androgen-regulated angiogenesis in prostate cancer. Cancers. 2017;9(4):32.10.3390/cancers9040032Suche in Google Scholar PubMed PubMed Central

[21] Zocco MA, Garcovich M, Lupascu A, Stasio ED, Roccarina D, Annicchiarico BE, et al. Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound. J Hepatology. 2013;59(5):1014–21.10.1016/j.jhep.2013.06.011Suche in Google Scholar PubMed

[22] Arakelyan L, Vainstein V, Agur Z. A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumor growth. Angiogenesis. 2002;5(3):203–14.10.1023/A:1023841921971Suche in Google Scholar PubMed

[23] Tang MX, Mulvana H, Gauthier T, Lim AKP, Stride E. Quantitative contrast-enhanced ultrasound imaging: A review of sources of variability. Interface Focus. 2011;1(4):520–39.10.1098/rsfs.2011.0026Suche in Google Scholar PubMed PubMed Central

[24] Shafiee R, Shariat A, Khalili S, Malayeri HZ, Mokarizadeh A, Anissian A, et al. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study. Tumor Biol. 2015;36(4):2437–45.10.1007/s13277-014-2854-4Suche in Google Scholar PubMed

[25] Zhang Q, Liu S, Zhang Q, Xiong Z, Wang AR, Myers L, et al. Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment. Prostate. 2014;74(8):869–79.10.1002/pros.22805Suche in Google Scholar PubMed PubMed Central

[26] Acosta AM, Al Rasheed MRH, Rauscher GH, Vormittag E, Mon KS, Sharif A, et al. Tumor necrosis in radical prostatectomies with high-grade prostate cancer is associated with multiple poor prognostic features and a high prevalence of residual disease. Hum Pathol. 2018;75:1–9.10.1016/j.humpath.2017.11.015Suche in Google Scholar PubMed

[27] Tomioka S, Nakatsu H, Suzuki N, Murakami S, Matsuzaki O, Shimazaki J. Comparison of Gleason grade and score between preoperative biopsy and prostatectomy specimens in prostate cancer. Int J Urol. 2006;13(5):555–9.10.1111/j.1442-2042.2006.01346.xSuche in Google Scholar PubMed

Received: 2022-12-16
Revised: 2023-06-27
Accepted: 2023-07-19
Published Online: 2023-08-09

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Research Articles
  2. Exosomes derived from mesenchymal stem cells overexpressing miR-210 inhibits neuronal inflammation and contribute to neurite outgrowth through modulating microglia polarization
  3. Current situation of acute ST-segment elevation myocardial infarction in a county hospital chest pain center during an epidemic of novel coronavirus pneumonia
  4. circ-IARS depletion inhibits the progression of non-small-cell lung cancer by circ-IARS/miR-1252-5p/HDGF ceRNA pathway
  5. circRNA ITGA7 restrains growth and enhances radiosensitivity by up-regulating SMAD4 in colorectal carcinoma
  6. WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
  7. Up-regulation of collagen type V alpha 2 (COL5A2) promotes malignant phenotypes in gastric cancer cell via inducing epithelial–mesenchymal transition (EMT)
  8. Inhibition of TERC inhibits neural apoptosis and inflammation in spinal cord injury through Akt activation and p-38 inhibition via the miR-34a-5p/XBP-1 axis
  9. 3D-printed polyether-ether-ketone/n-TiO2 composite enhances the cytocompatibility and osteogenic differentiation of MC3T3-E1 cells by downregulating miR-154-5p
  10. Propofol-mediated circ_0000735 downregulation restrains tumor growth by decreasing integrin-β1 expression in non-small cell lung cancer
  11. PVT1/miR-16/CCND1 axis regulates gastric cancer progression
  12. Silencing of circ_002136 sensitizes gastric cancer to paclitaxel by targeting the miR-16-5p/HMGA1 axis
  13. Short-term outcomes after simultaneous gastrectomy plus cholecystectomy in gastric cancer: A pooling up analysis
  14. SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
  15. Molecular mechanism by which the Notch signaling pathway regulates autophagy in a rat model of pulmonary fibrosis in pigeon breeder’s lung
  16. lncRNA TPT1-AS1 promotes cell migration and invasion in esophageal squamous-cell carcinomas by regulating the miR-26a/HMGA1 axis
  17. SIRT1/APE1 promotes the viability of gastric cancer cells by inhibiting p53 to suppress ferroptosis
  18. Glycoprotein non-metastatic melanoma B interacts with epidermal growth factor receptor to regulate neural stem cell survival and differentiation
  19. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
  20. Association of osteoporosis and skeletal muscle loss with serum type I collagen carboxyl-terminal peptide β glypeptide: A cross-sectional study in elder Chinese population
  21. circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway
  22. Delivery in a vertical birth chair supported by freedom of movement during labor: A randomized control trial
  23. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling
  24. Metabolic resuscitation therapy in critically ill patients with sepsis and septic shock: A pilot prospective randomized controlled trial
  25. Lycopene ameliorates locomotor activity and urinary frequency induced by pelvic venous congestion in rats
  26. UHRF1-induced connexin26 methylation is involved in hearing damage triggered by intermittent hypoxia in neonatal rats
  27. LINC00511 promotes melanoma progression by targeting miR-610/NUCB2
  28. Ultra-high-performance liquid chromatography-tandem mass spectrometry analysis of serum metabolomic characteristics in people with different vitamin D levels
  29. Role of Jumonji domain-containing protein D3 and its inhibitor GSK-J4 in Hashimoto’s thyroiditis
  30. circ_0014736 induces GPR4 to regulate the biological behaviors of human placental trophoblast cells through miR-942-5p in preeclampsia
  31. Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies
  32. Effects of osteogenic growth peptide C-terminal pentapeptide and its analogue on bone remodeling in an osteoporosis rat model
  33. A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma
  34. WGCNA-based identification of potential targets and pathways in response to treatment in locally advanced breast cancer patients
  35. Radiomics model using preoperative computed tomography angiography images to differentiate new from old emboli of acute lower limb arterial embolism
  36. Dysregulated lncRNAs are involved in the progress of myocardial infarction by constructing regulatory networks
  37. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy
  38. Genetic polymorphisms of MRPS30-DT and NINJ2 may influence lung cancer risk
  39. Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
  40. Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
  41. Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
  42. CircRANBP17 modulated KDM1A to regulate neuroblastoma progression by sponging miR-27b-3p
  43. Exosomal miR-93-5p regulated the progression of osteoarthritis by targeting ADAMTS9
  44. Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
  45. HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway
  46. The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study
  47. Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
  48. A novel long noncoding RNA AC125257.1 facilitates colorectal cancer progression by targeting miR-133a-3p/CASC5 axis
  49. Impact of omicron wave and associated control measures in Shanghai on health management and psychosocial well-being of patients with chronic conditions
  50. Clinicopathological characteristics and prognosis of young patients aged ≤45 years old with non-small cell lung cancer
  51. TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
  52. The dose limits of teeth protection for patients with nasopharyngeal carcinoma undergoing radiotherapy based on the early oral health-related quality of life
  53. miR-30b-5p targeting GRIN2A inhibits hippocampal damage in epilepsy
  54. Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells
  55. IRF6 and FGF1 polymorphisms in non-syndromic cleft lip with or without cleft palate in the Polish population
  56. Comprehensive analysis of the role of SFXN family in breast cancer
  57. Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
  58. Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression
  59. AG1024, an IGF-1 receptor inhibitor, ameliorates renal injury in rats with diabetic nephropathy via the SOCS/JAK2/STAT pathway
  60. Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
  61. Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment
  62. Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3
  63. The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma
  64. Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
  65. Ultrasound examination supporting CT or MRI in the evaluation of cervical lymphadenopathy in patients with irradiation-treated head and neck cancer
  66. F-box and WD repeat domain containing 7 inhibits the activation of hepatic stellate cells by degrading delta-like ligand 1 to block Notch signaling pathway
  67. Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the miR-665/NOTCH1 axis
  68. Long noncoding RNA Mhrt alleviates angiotensin II-induced cardiac hypertrophy phenotypes by mediating the miR-765/Wnt family member 7B pathway
  69. Effect of miR-499-5p/SOX6 axis on atrial fibrosis in rats with atrial fibrillation
  70. Cholesterol induces inflammation and reduces glucose utilization
  71. circ_0004904 regulates the trophoblast cell in preeclampsia via miR-19b-3p/ARRDC3 axis
  72. NECAB3 promotes the migration and invasion of liver cancer cells through HIF-1α/RIT1 signaling pathway
  73. The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
  74. miR-2053 inhibits the growth of ovarian cancer cells by downregulating SOX4
  75. Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis
  76. α-Hederin regulates macrophage polarization to relieve sepsis-induced lung and liver injuries in mice
  77. Changes of microbiota level in urinary tract infections: A meta-analysis
  78. Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions
  79. Falls during oxaliplatin-based chemotherapy for gastrointestinal malignancies – (lessons learned from) a prospective study
  80. Outcomes of low-risk birth care during the Covid-19 pandemic: A cohort study from a tertiary care center in Lithuania
  81. Vitamin D protects intestines from liver cirrhosis-induced inflammation and oxidative stress by inhibiting the TLR4/MyD88/NF-κB signaling pathway
  82. Integrated transcriptome analysis identifies APPL1/RPS6KB2/GALK1 as immune-related metastasis factors in breast cancer
  83. Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
  84. Circular RNA Circ_0038467 promotes the maturation of miRNA-203 to increase lipopolysaccharide-induced apoptosis of chondrocytes
  85. An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy
  86. Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
  87. Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
  88. PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma
  89. miR-141-3p accelerates ovarian cancer progression and promotes M2-like macrophage polarization by targeting the Keap1-Nrf2 pathway
  90. lncRNA OIP5-AS1 attenuates the osteoarthritis progression in IL-1β-stimulated chondrocytes
  91. Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer
  92. Subjective well-being in informal caregivers during the COVID-19 pandemic
  93. Nrf2 protects against myocardial ischemia-reperfusion injury in diabetic rats by inhibiting Drp1-mediated mitochondrial fission
  94. Unfolded protein response inhibits KAT2B/MLKL-mediated necroptosis of hepatocytes by promoting BMI1 level to ubiquitinate KAT2B
  95. Bladder cancer screening: The new selection and prediction model
  96. circNFATC3 facilitated the progression of oral squamous cell carcinoma via the miR-520h/LDHA axis
  97. Prone position effect in intensive care patients with SARS-COV-2 pneumonia
  98. Clinical observation on the efficacy of Tongdu Tuina manipulation in the treatment of primary enuresis in children
  99. Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway
  100. Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway
  101. Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19
  102. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study
  103. Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
  104. Clinical significance of serum MBD3 detection in girls with central precocious puberty
  105. Clinical features of varicella-zoster virus caused neurological diseases detected by metagenomic next-generation sequencing
  106. Collagen treatment of complex anorectal fistula: 3 years follow-up
  107. LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424
  108. Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
  109. SMOC2 plays a role in heart failure via regulating TGF-β1/Smad3 pathway-mediated autophagy
  110. A prospective cohort study of the impact of chronic disease on fall injuries in middle-aged and older adults
  111. circRNA THBS1 silencing inhibits the malignant biological behavior of cervical cancer cells via the regulation of miR-543/HMGB2 axis
  112. hsa_circ_0000285 sponging miR-582-3p promotes neuroblastoma progression by regulating the Wnt/β-catenin signaling pathway
  113. Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial–mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis
  114. lncRNA UCA1 regulates miR-132/Lrrfip1 axis to promote vascular smooth muscle cell proliferation
  115. Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia
  116. Hsa-miR-223-3p participates in the process of anthracycline-induced cardiomyocyte damage by regulating NFIA gene
  117. Anti-inflammatory effect of ApoE23 on Salmonella typhimurium-induced sepsis in mice
  118. Analysis of somatic mutations and key driving factors of cervical cancer progression
  119. Hsa_circ_0028007 regulates the progression of nasopharyngeal carcinoma through the miR-1179/SQLE axis
  120. Variations in sexual function after laparoendoscopic single-site hysterectomy in women with benign gynecologic diseases
  121. Effects of pharmacological delay with roxadustat on multi-territory perforator flap survival in rats
  122. Analysis of heroin effects on calcium channels in rat cardiomyocytes based on transcriptomics and metabolomics
  123. Risk factors of recurrent bacterial vaginosis among women of reproductive age: A cross-sectional study
  124. Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells
  125. Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
  126. Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer
  127. The protective effect of caffeic acid phenethyl ester in the nephrotoxicity induced by α-cypermethrin
  128. Norepinephrine alleviates cyclosporin A-induced nephrotoxicity by enhancing the expression of SFRP1
  129. Effect of RUNX1/FOXP3 axis on apoptosis of T and B lymphocytes and immunosuppression in sepsis
  130. The function of Foxp1 represses β-adrenergic receptor transcription in the occurrence and development of bladder cancer through STAT3 activity
  131. Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU
  132. Calycosin protects against chronic prostatitis in rats via inhibition of the p38MAPK/NF-κB pathway
  133. Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
  134. The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
  135. Circ-UBR4 regulates the proliferation, migration, inflammation, and apoptosis in ox-LDL-induced vascular smooth muscle cells via miR-515-5p/IGF2 axis
  136. Clinical characteristics of current COVID-19 rehabilitation outpatients in China
  137. Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling
  138. miR-199a-5p inhibits aortic valve calcification by targeting ATF6 and GRP78 in valve interstitial cells
  139. The application of iliac fascia space block combined with esketamine intravenous general anesthesia in PFNA surgery of the elderly: A prospective, single-center, controlled trial
  140. Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
  141. The effects of progesterone on the healing of obstetric anal sphincter damage in female rats
  142. Identification of cuproptosis-related genes for predicting the development of prostate cancer
  143. Lumican silencing ameliorates β-glycerophosphate-mediated vascular smooth muscle cell calcification by attenuating the inhibition of APOB on KIF2C activity
  144. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase
  145. A single center prospective study: Influences of different hip flexion angles on the measurement of lumbar spine bone mineral density by dual energy X-ray absorptiometry
  146. Clinical analysis of AN69ST membrane continuous venous hemofiltration in the treatment of severe sepsis
  147. Antibiotics therapy combined with probiotics administered intravaginally for the treatment of bacterial vaginosis: A systematic review and meta-analysis
  148. Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma
  149. A pan-cancer analysis of STAT3 expression and genetic alterations in human tumors
  150. A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma
  151. Pepsin concentration in oral lavage fluid of rabbit reflux model constructed by dilating the lower esophageal sphincter
  152. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
  153. Tanshinone IIA attenuates valvular interstitial cells’ calcification induced by oxidized low density lipoprotein via reducing endoplasmic reticulum stress
  154. AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy
  155. Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes
  156. Trial protocol: Feasibility of neuromodulation with connectivity-guided intermittent theta-burst stimulation for improving cognition in multiple sclerosis
  157. LncRNA LINC00592 mediates the promoter methylation of WIF1 to promote the development of bladder cancer
  158. Factors associated with gastrointestinal dysmotility in critically ill patients
  159. Mechanisms by which spinal cord stimulation intervenes in atrial fibrillation: The involvement of the endothelin-1 and nerve growth factor/p75NTR pathways
  160. Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics
  161. Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1
  162. Menstrual irregularities associated with COVID-19 vaccines among women in Saudi Arabia: A survey during 2022
  163. Ferroptosis involves in Schwann cell death in diabetic peripheral neuropathy
  164. The effect of AQP4 on tau protein aggregation in neurodegeneration and persistent neuroinflammation after cerebral microinfarcts
  165. Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
  166. Analysis of clinical characteristics in proximal and distal reflux monitoring among patients with gastroesophageal reflux disease
  167. Exosomal circ-0020887 and circ-0009590 as novel biomarkers for the diagnosis and prediction of short-term adverse cardiovascular outcomes in STEMI patients
  168. Upregulated microRNA-429 confers endometrial stromal cell dysfunction by targeting HIF1AN and regulating the HIF1A/VEGF pathway
  169. Bibliometrics and knowledge map analysis of ultrasound-guided regional anesthesia
  170. Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways
  171. D-dimer trends predict COVID-19 patient’s prognosis: A retrospective chart review study
  172. WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
  173. Using of endoscopic polypectomy in patients with diagnosed malignant colorectal polyp – The cross-sectional clinical study
  174. Anti-S100A4 antibody administration alleviates bronchial epithelial–mesenchymal transition in asthmatic mice
  175. Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
  176. Prevalence and antibiogram of bacteria causing urinary tract infection among patients with chronic kidney disease
  177. Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development?
  178. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
  179. A new technique for uterine-preserving pelvic organ prolapse surgery: Laparoscopic rectus abdominis hysteropexy for uterine prolapse by comparing with traditional techniques
  180. Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes
  181. A comparative study on the overlapping effects of clinically applicable therapeutic interventions in patients with central nervous system damage
  182. Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome: Long-term follow-up
  183. The diagnostic accuracy of touch imprint cytology for sentinel lymph node metastases of breast cancer: An up-to-date meta-analysis of 4,073 patients
  184. Mortality associated with Sjögren’s syndrome in the United States in the 1999–2020 period: A multiple cause-of-death study
  185. CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
  186. Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations
  187. KMT2A maintains stemness of gastric cancer cells through regulating Wnt/β-catenin signaling-activated transcriptional factor KLF11
  188. Evaluation of placental oxygenation by near-infrared spectroscopy in relation to ultrasound maturation grade in physiological term pregnancies
  189. The role of ultrasonographic findings for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
  190. Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
  191. Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
  192. Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients
  193. Integrative bioinformatics analysis reveals STAT2 as a novel biomarker of inflammation-related cardiac dysfunction in atrial fibrillation
  194. Adipose-derived stem cells repair radiation-induced chronic lung injury via inhibiting TGF-β1/Smad 3 signaling pathway
  195. Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
  196. lncRNA LENGA sponges miR-378 to promote myocardial fibrosis in atrial fibrillation
  197. Diagnostic value of urinary Tamm-Horsfall protein and 24 h urine osmolality for recurrent calcium oxalate stones of the upper urinary tract: Cross-sectional study
  198. The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer
  199. The spike protein of SARS-CoV-2 induces inflammation and EMT of lung epithelial cells and fibroblasts through the upregulation of GADD45A
  200. Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
  201. MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathway
  202. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids
  203. Cimifugin inhibits adipogenesis and TNF-α-induced insulin resistance in 3T3-L1 cells
  204. Predictors of gastrointestinal complaints in patients on metformin therapy
  205. Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation
  206. A retrospective analysis of the effect of latent tuberculosis infection on clinical pregnancy outcomes of in vitro fertilization–fresh embryo transferred in infertile women
  207. Appropriateness and clinical outcomes of short sustained low-efficiency dialysis: A national experience
  208. miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD
  209. Clinical features and management of lymphoepithelial cyst
  210. Serum VEGF, high-sensitivity CRP, and cystatin-C assist in the diagnosis of type 2 diabetic retinopathy complicated with hyperuricemia
  211. ENPP1 ameliorates vascular calcification via inhibiting the osteogenic transformation of VSMCs and generating PPi
  212. Significance of monitoring the levels of thyroid hormone antibodies and glucose and lipid metabolism antibodies in patients suffer from type 2 diabetes
  213. The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study
  214. Interleukin 33, soluble suppression of tumorigenicity 2, interleukin 27, and galectin 3 as predictors for outcome in patients admitted to intensive care units
  215. Identification of diagnostic immune-related gene biomarkers for predicting heart failure after acute myocardial infarction
  216. Long-term administration of probiotics prevents gastrointestinal mucosal barrier dysfunction in septic mice partly by upregulating the 5-HT degradation pathway
  217. miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor
  218. Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
  219. Review Articles
  220. Prenatal diagnosis of fetal defects and its implications on the delivery mode
  221. Electromagnetic fields exposure on fetal and childhood abnormalities: Systematic review and meta-analysis
  222. Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae
  223. Saddle pulmonary embolism in the setting of COVID-19 infection: A systematic review of case reports and case series
  224. Vitamin C and epigenetics: A short physiological overview
  225. Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
  226. Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
  227. Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review
  228. Surgical management and outcomes of traumatic global brachial plexus injury: A concise review and our center approach
  229. The progress of autoimmune hepatitis research and future challenges
  230. METTL16 in human diseases: What should we do next?
  231. New insights into the prevention of ureteral stents encrustation
  232. VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
  233. Case Reports
  234. Mycobacterium xenopi infection of the kidney and lymph nodes: A case report
  235. Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report
  236. Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report
  237. Liver abscess complicated with multiple organ invasive infection caused by hematogenous disseminated hypervirulent Klebsiella pneumoniae: A case report
  238. Urokinase-based lock solutions for catheter salvage: A case of an upcoming kidney transplant recipient
  239. Two case reports of maturity-onset diabetes of the young type 3 caused by the hepatocyte nuclear factor 1α gene mutation
  240. Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
  241. Does total hip arthroplasty result in intercostal nerve injury? A case report and literature review
  242. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi – Case report and literature review
  243. Synchronous triple primary gastrointestinal malignant tumors treated with laparoscopic surgery: A case report
  244. CT-guided percutaneous microwave ablation combined with bone cement injection for the treatment of transverse metastases: A case report
  245. Malignant hyperthermia: Report on a successful rescue of a case with the highest temperature of 44.2°C
  246. Anesthetic management of fetal pulmonary valvuloplasty: A case report
  247. Rapid Communication
  248. Impact of COVID-19 lockdown on glycemic levels during pregnancy: A retrospective analysis
  249. Erratum
  250. Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
  251. Erratum to: “Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p”
  252. Retraction
  253. Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
  254. Retraction of “circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis”
  255. Retraction of “miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells”
  256. Retraction of “SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis”
  257. Retraction of “circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury”
  258. Retraction of “lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells”
  259. Special issue Linking Pathobiological Mechanisms to Clinical Application for cardiovascular diseases
  260. Effect of cardiac rehabilitation therapy on depressed patients with cardiac insufficiency after cardiac surgery
  261. Special issue The evolving saga of RNAs from bench to bedside - Part I
  262. FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
  263. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part III
  264. Development of a machine learning-based signature utilizing inflammatory response genes for predicting prognosis and immune microenvironment in ovarian cancer
Heruntergeladen am 22.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/med-2023-0772/html
Button zum nach oben scrollen